NASH - Nonalcoholic Steatohepatitis Clinical Trials in Fayetteville, NC

A listing of NASH - Nonalcoholic Steatohepatitis Clinical Trials in Fayetteville, NC actively recruiting patient volunteers.

Search by Name
Search
Filter by Condition
NASH - Nonalcoholic Steatohepatitis
3 trials found

A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH)

NCT04880031

This is a safety study to evaluate BOS-580 administered subcutaneously over 12 weeks in Part A or 24 weeks in Part B.

Conditions: Nonalcoholic Steatohepatitis (NASH)

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

NCT04849728

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Conditions: NASH - Nonalcoholic Steatohepatitis

A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

NCT03900429

A double-blind placebo controlled randomized Phase 3 study to determine if 80 or 100 mg of MGL-3196 as compared with placebo resolves NASH and/or reduces fibrosis on liver biopsy and prevents progression to cirrhosis and/or advanced liver disease

Conditions: NASH - Nonalcoholic Steatohepatitis

Browse NASH - Nonalcoholic Steatohepatitis Clinical Trials in Other North Carolina Cities